USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 16, 2021 (est) | Sep 30, 2021 | - | $-0.06 | $-0.02 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 16, 2021 (est) | Sep 30, 2021 | - | $0.00 | $0.00 |
Greenwich Lifesciences's next estimated earnings date (based on same quarter last year's date) is Nov 16, 2021 for the fiscal quarter ending Sep 30, 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $-0.23 | $-0.23 | $-0.23 |
| Dec 2022 | 1 | $-0.59 | $-0.59 | $-0.59 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.23 | $-1.16 | $-1.16 |
| Dec 2022 | 0 / 0 | $-0.59 | $-1.29 | $-1.29 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 1 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 13, 2021 | Jun 2021 | $-0.32 | $-0.06 | 81.25% |
| May 20, 2021 | Mar 2021 | $-0.32 | $-0.05 | 84.38% |
| Mar 31, 2021 | Dec 2020 | $-0.93 | $-0.12 | 87.10% |
| Nov 16, 2020 | Sep 2020 | - | $-0.02 | - |
| Sep 30, 2020 | Jun 2020 | - | $-0.03 | - |
| Jun 30, 2020 | Mar 2020 | - | $-0.02 | - |
| Mar 31, 2020 | Dec 2019 | - | $-0.03 | - |
| Sep 30, 2019 | Jun 2019 | - | $-1.15 | - |
| Jun 30, 2019 | Mar 2019 | - | $-12.83 | - |
| Mar 31, 2019 | Dec 2018 | - | $-0.73 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $-1.02 | $-0.20 | - |
| Mar 31, 2020 | Dec 2019 | - | $-14.01 | - |
| Mar 31, 2019 | Dec 2018 | - | $-0.73 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 13, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 20, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 31, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 16, 2020 | Sep 2020 | - | $0.00 | - |
| Sep 30, 2020 | Jun 2020 | - | $0.00 | - |
| Jun 30, 2020 | Mar 2020 | - | $0.00 | - |
| Mar 31, 2020 | Dec 2019 | - | $0.00 | - |
| Sep 30, 2019 | Jun 2019 | - | - | - |
| Jun 30, 2019 | Mar 2019 | - | - | - |
| Mar 31, 2019 | Dec 2018 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 31, 2020 | Dec 2019 | - | $0.00 | - |
| Mar 31, 2019 | Dec 2018 | - | $0.00 | - |
GLSI's next estimated earnings date (based on same quarter last year's report date) is Nov 16, 2021 for the fiscal quarter ending Sep 30, 2021.
Greenwich Lifesciences's previous earnings date was Aug 13, 2021 for its fiscal quarter ended Jun 30, 2021.
GLSI's earnings per share (EPS) was $-0.06, beating the consensus analysts forecast of $-0.32 by 81.25%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 20.00%, and lower than the same period a year before (Jun 2020) by 105.48%.
Revenues were $0.00.
The company reported a net income of $-749.75K.Free cash flow for the quarter was $-604.32K , compared to $-528.27K last quarter and $0.00 a year before.
Greenwich Lifesciences's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.
GLSI's earnings per share (EPS) was $-0.20, beating the consensus analysts forecast of $-1.02 by -80.86% , and higher than the previous year's EPS (Dec 2019) by -98.61%.
Revenues were $0.00.
The company reported a net income of $-1.86M.
Greenwich Lifesciences reported a free cash flow of $-1.15M for its fiscal year, compared to $-293.27K a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
